Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Shanghai S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 17.66 CNY | -2.91% |
|
-1.40% | +0.23% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13.55x | 2.54x | 0.65x | 0.55x | 4.41x | 7.28x | 5.1% | 2.99B | |
| 17.67x | 1.59x | 1.7x | 0.74x | 11.03x | 12x | -.--% | 15.73B | |
| 21.72x | 2.44x | 2.83x | 0.84x | 14.16x | 14.43x | 1.03% | 6.72B | |
| 16.65x | 1.72x | 1.6x | 0.75x | 7.8x | 9.78x | 2.24% | 6.36B | |
| 14.95x | 2.27x | 0.84x | 0.98x | 7.06x | 9.25x | 2.82% | 4.32B | |
| 14.56x | 4.41x | 24.33x | 1.25x | 7.64x | 14.32x | 5.52% | 3.24B | |
| 14.4x | 6.51x | 2.2x | 0.87x | 6.52x | 9.07x | 4.46% | 3.05B | |
| 30.9x | - | 0.54x | - | - | - | - | 2.4B | |
| 20.66x | 3.62x | 0.9x | 0.6x | 7.69x | 12.59x | 1.99% | 1.55B | |
| -107.27x | 2.65x | 1.55x | 0.44x | 16.17x | 69.61x | 0.02% | 1.49B | |
| 12.43x | 0.89x | 0.12x | 0.3x | 2.88x | 5.93x | 4.08% | 992M | |
| 18.14x | 2.19x | -0.42x | 0.83x | 7.55x | 17.82x | 5.87% | 878M | |
| 40.32x | 3.85x | -6.2x | 0.94x | 11.77x | 23.17x | - | 866M | |
| 26.53x | 7.23x | 0.98x | 0.96x | 13.09x | 20.3x | 1.35% | 815M | |
| 14.35x | 1.94x | 1.18x | 0.69x | 8.42x | 13.59x | 0.36% | 718M | |
| Average | 11.30x | 3.13x | 2.19x | 0.77x | 9.01x | 17.08x | 2.68% | 3.47B | |
| Weighted average by Cap. | 14.73x | 2.55x | 2.84x | 0.79x | 9.63x | 13.57x | 1.92% |
Select your edition
All financial news and data tailored to specific country editions
